In a retrospective analysis of six patients with post-transplant relapse of ATLL treated with MOG, Inoue et al. reported that, although ATLL cells in PB disappeared rapidly after MOG administration, LN lesions were resistant to MOG [20]. The gene discussed is MOG; the disease is adult T-cell leukemia/lymphoma.